APA (7th ed.) Citation

Dormann, H., Neubert, A., Criegee-Rieck, M., Egger, T., Radespiel-Tröger, M., Azaz-Livshits, T., . . . Hahn, E. (2004). Readmissions and adverse drug reactions in internal medicine: The economic impact. Journal of Internal Medicine, 255(6), 653. https://doi.org/10.1111/j.1365-2796.2004.01326.x

Chicago Style (17th ed.) Citation

Dormann, H., A. Neubert, M. Criegee-Rieck, T. Egger, M. Radespiel-Tröger, T. Azaz-Livshits, M. Levy, K. Brune, and E.G Hahn. "Readmissions and Adverse Drug Reactions in Internal Medicine: The Economic Impact." Journal of Internal Medicine 255, no. 6 (2004): 653. https://doi.org/10.1111/j.1365-2796.2004.01326.x.

MLA (9th ed.) Citation

Dormann, H., et al. "Readmissions and Adverse Drug Reactions in Internal Medicine: The Economic Impact." Journal of Internal Medicine, vol. 255, no. 6, 2004, p. 653, https://doi.org/10.1111/j.1365-2796.2004.01326.x.